Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Buse

Showing results (1-10 of 457) with videos related to

Pageof 46
Sort By:
Diabetes Care|August 28, 2003
Should postprandial glucose be routinely measured and treated to a particular target? Connecting the two sides of the debateJohn B Buse
Nature Clinical Practice. Endocrinology & Metabolism|June 19, 2008
Are prescribing patterns of antidiabetic medications influenced by fears of litigation?John B Buse
Nature Reviews. Endocrinology|January 26, 2011
Type 2 diabetes mellitus in 2010: individualizing treatment targets in diabetes careJohn B Buse
Diabetes Care|April 30, 2003
Should postprandial glucose be routinely measured and treated to a particular target? No!John B Buse
Transactions of the American Clinical and Climatological Association|September 3, 2015
Glycemic Targets in Diabetes Care: Emerging Clarity after AccordJohn B Buse
Circulation|August 27, 2003
Glitazones and heart failure: critical appraisal for the clinicianJohn B Buse
Diabetes Care|October 31, 2009
Can we become victims of our own success?John B Buse
Diabetes Care|December 1, 2010
Screening for diabetes and prediabetes with proposed A1C-based diagnostic criteria: comment on Olson et alJohn B Buse
The Journal of Clinical Psychiatry|March 27, 2002
Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetesJohn B Buse
The New England Journal of Medicine|November 3, 2016
Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesJohn B Buse,
Pageof 46

Showing results (1-10 of 457) with videos related to

Sort By:
Pageof 46
Diabetes Care|August 28, 2003
Should postprandial glucose be routinely measured and treated to a particular target? Connecting the two sides of the debateJohn B Buse
Nature Clinical Practice. Endocrinology & Metabolism|June 19, 2008
Are prescribing patterns of antidiabetic medications influenced by fears of litigation?John B Buse
Nature Reviews. Endocrinology|January 26, 2011
Type 2 diabetes mellitus in 2010: individualizing treatment targets in diabetes careJohn B Buse
Diabetes Care|April 30, 2003
Should postprandial glucose be routinely measured and treated to a particular target? No!John B Buse
Transactions of the American Clinical and Climatological Association|September 3, 2015
Glycemic Targets in Diabetes Care: Emerging Clarity after AccordJohn B Buse
Circulation|August 27, 2003
Glitazones and heart failure: critical appraisal for the clinicianJohn B Buse
Diabetes Care|October 31, 2009
Can we become victims of our own success?John B Buse
Diabetes Care|December 1, 2010
Screening for diabetes and prediabetes with proposed A1C-based diagnostic criteria: comment on Olson et alJohn B Buse
The Journal of Clinical Psychiatry|March 27, 2002
Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetesJohn B Buse
The New England Journal of Medicine|November 3, 2016
Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesJohn B Buse,
Pageof 46